AI-generated summary
The authors studied 70 patients with refractory Meibomian gland dysfunction, comparing combined intense pulsed light and low-level light therapy with topical hyaluronate drops over 6 months. They report improvements in several dry eye and gland measures in the light therapy group, with differences from the drop group at 6 months, and no adverse events recorded.
- Participants
- 70
- Who or what was studied
- Patients with refractory Meibomian gland dysfunction
- Limits stated in the abstract
- The abstract does not describe randomization or blinding, and the comparison group received a different treatment type.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.